Search

everythinglearnresearchcommunity

for

Search:↓

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Children with systemic lupus erythematosus have different skin symptoms than adults.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Early identification of lupus through skin signs and blood tests is crucial in India.

Pregnant women with Systemic Lupus Erythematosus have a higher risk of blood clotting problems.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

Early diagnosis and quick treatment are crucial for severe lupus cases.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Certain skin symptoms can help detect and manage systemic lupus.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

Looking at skin can help find and treat serious diseases early.

Hydroxychloroquine may help delay skin damage in lupus patients.

Prednisone has risks for lupus patients, isotretinoin is safe for mental health, transplant patients risk skin cancer, and various treatments are effective for specific skin conditions.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.